|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 551 studies with search of: | Glioblastoma |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Evaluation of [18F]-FMISO for Non Operated Glioblastoma
|
||||
| 2 | Recruiting |
Study of Bevacizumab Plus Temodar and Tarceva in Patients With Glioblastoma or Gliosarcoma
|
||||
| 3 | Recruiting |
Phase I/II Sorafenib With Radiation and Temozolomide in Newly Diagnosed Glioblastoma or Gliosarcoma
|
||||
| 4 | Not yet recruiting |
Convection Enhanced Localized Administration of PRX321 With Real-Time Imaging for Therapy of Recurrent Glioblastoma (CLARITY-1)
|
||||
| 5 | Recruiting |
Study With Nelfinavir and Combined Radiochemotherapy for Glioblastoma
|
||||
| 6 | Active, not recruiting |
Study of Lenalidomide and XRT in Patients With Newly Diagnosed Glioblastoma Multiforme
|
||||
| 7 | Recruiting |
Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients
|
||||
| 8 | Recruiting |
PTK787/ZK 222584 in Combination With Temozolomide and Radiation in Patients With Glioblastoma Taking Enzyme-Inducing Anti-Epileptic Drugs
|
||||
| 9 | Recruiting |
Safety Study of XL184 in Combination With Temozolomide and Radiation Therapy in the Initial Treatment of Adults With Glioblastoma
|
||||
| 10 | Active, not recruiting |
Efficacy Study of TLN-4601 in Patients With Recurring Glioblastoma Multiforme
|
||||
| 11 | Completed |
Pegylated Liposomal Doxorubicine and Prolonged Temozolomide in Addition to Radiotherapy in Newly Diagnosed Glioblastoma
|
||||
| 12 | Recruiting |
Dasatinib Plus Radiation Therapy/Temozolomide in Newly-Diagnosed Glioblastoma
|
||||
| 13 | Withdrawn |
Study of Therapy With TransMID™ Compared to Best Standard of Care in Patients With Glioblastoma Multiforme
|
||||
| 14 | Recruiting |
Study of XL184 in Adults With Glioblastoma Multiforme
|
||||
| 15 | Active, not recruiting |
Measuring Non-Enhancing Glioblastoma Progression
|
||||
| 16 | Terminated |
Phase II Study of Temozolomide in Newly Diagnosed Glioblastoma
|
||||
| 17 | Terminated |
Boron Neutron Capture Therapy (BNCT) as Treatment of Glioblastoma
|
||||
| 18 | Recruiting |
Dose-Intense Temozolomide in Recurrent Glioblastoma
|
||||
| 19 | Active, not recruiting |
Radiation Therapy and Temozolomide Followed by Temozolomide Plus Sorafenib for Glioblastoma Multiforme
|
||||
| 20 | Recruiting |
Vorinostat, Isotretinoin and Carboplatin in Adults With Recurrent Glioblastoma Multiforme (GBM)
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|